V2X (VVX) delivered a third quarter that looks better against consensus than against the bar investors actually set. Adjusted EPS of $1.64 topped the $1.54 consensus but fell 2.4% short of the $1.68 Earnings Whisper number. Revenue of $1.271 billion beat the $1.23 billion consensus by 3.4%. Earnings grew 19.7% year over year and revenue rose 8.9%, and management raised full-year guidance on every metric for the third consecutive call. That is the central tension. The headline growth and the guidance raise are real, but quarterly revenue growth has now slowed from 23% in Q1 to 17% in Q2 to 9% in Q3. The updated outlook implies low-single-digit growth in Q4, and the raised guidance landed in line with estimates rather than ahead of them.

The composition of the beat deserves scrutiny. Adjusted EBITDA rose only 4% to $88.6 million, and margin slipped to 7.0% from 7.3% a year ago and 7.1% in Q2. GAAP operating income grew about 7% to $59.5 million, while SG&A climbed faster than revenue. A meaningful share of the bottom-line leverage came below the operating line. Net interest expense fell to $15.5 million from $20.0 million as the company paid down debt, which helped push GAAP diluted EPS up 32% to $1.01. Deleveraging is a legitimate and durable earnings driver. Still, it is not the same as operating margin expansion, and investors looking for the latter did not get it this quarter.

Beneath the totals, the revenue base is shifting sharply. U.S. revenue jumped 30.6%, while Middle East revenue fell 30.2%. Management said Kuwait has stepped down to roughly $25 million for the second half and expects the region to decline again in 2027. By customer, Army revenue fell 24.8%, while Air Force rose 50% and Other jumped 83%. Within Other, national-security work contributed $130 million, up from about $100 million in Q2, and has been extended through mid-2027. Contract mix is moving too. Time-and-materials revenue soared 470%, and management said cost-type work has fallen to roughly 54-55% of the mix from about 60%. Management describes new awards as margin-accretive, but that benefit is not yet visible in reported margins.

The forward-looking evidence is where bulls have the stronger hand:

• **Bookings:** Q3 book-to-bill rebounded to 1.2x from 0.5x in Q2. Funded backlog edged up to $2.6 billion, though total backlog of $12.8 billion remains below the Q1 record of $13.8 billion. Management also quantified roughly $800 million of year-to-date on-contract growth bookings for the first time.
• **2027 setup:** Recompete exposure is only about 6% of 2027 revenue, and the T6 program adds a full year at a $250-300 million run rate.
• **Products:** The Tempest counter-UAS franchise grew from one customer to five, and R&D spending is running about 2.3x 2025 levels.
• **Preliminary 2027 view:** Management offered its first look, calling for growth in revenue, margins, adjusted EPS and cash flow. However, it declined to quantify the outlook, citing award timing and the election cycle, and said margin gains would be back-half weighted.
• **Q4 execution risk:** The full-year EBITDA guide requires an implied Q4 margin near 7.7%, a notable step up from Q3's 7.0%.

Cash flow and the balance sheet were clear positives. Adjusted operating cash flow reached $61.8 million versus $35.8 million a year earlier, and full-year cash guidance was raised for the first time this year to $175-195 million. Net debt fell $140.3 million year over year, leverage stands at 2.2x, and management targets about 2.0x by year-end. One caveat on cash: year-to-date GAAP operating cash flow is still negative at $41.0 million. The positive adjusted figure depends on excluding $141 million of receivables-facility activity.

Investor sentiment deteriorated meaningfully into the report, falling from -0.23 to -0.44. Expectations were becoming more skeptical even as the whisper number sat above consensus. The stock's path has been volatile:

• Shares peaked at $86.24 shortly after the August report.
• They slid to $66.83 by mid-October.
• They then rebounded sharply to $80.37, about 1.8% below the post-Q2 opening price.

That leaves the stock 8.9% above its 200-day moving average and 20% off its quarterly low, so much of the recovery was already priced in before the print. The Earnings Whispers trend readings are mostly positive, with sequential growth and momentum improving, while the price trend remains neutral.

The bottom line is that V2X keeps raising numbers, strengthening its balance sheet and building a credible 2027 narrative around products, national-security work and limited recompete risk. However, the quarter fell short of the whisper. Margins are flat to down, revenue growth is decelerating toward low single digits, and a shrinking Middle East business is a real headwind. Investors must take the margin inflection on management's word until the implied Q4 step-up actually shows up.